FDA Recalls and Warnings: Gas-X Contaminated With Coolant; More Generic Cymbalta Cancer Risks, Supplements Linked to Salmonella Outbreak - MedShadow Foundation
Recent FDA recalls and warnings highlight contamination risks in supplements, including a salmonella outbreak linked to supplements and a coolant contamination in Gas-X. These events underscore the need for strict GMP compliance and robust quality control.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; ongoing compliance monitoring required.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Increased FDA scrutiny and enforcement actions due to contamination incidents (salmonella, coolant) in supplements and over-the-counter drugs.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
Review and enhance quality control and GMP procedures, ensure supplier verification, and monitor FDA warning letters and recalls for relevant products.
Deadline
Immediately; ongoing compliance monitoring required.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire
- After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
- US FDA New Dietary Ingredient Notification Submissions in the Last 4 Years - CIRS Group
- FDA's 2016 New Dietary Ingredient Draft Guidance - Food and Drug Law Institute (FDLI)